Similar to chemotherapy and iron chelation, increased expression of ferritin heavy chain 1 (FTH1) suppresses the expression of cellular myelocytomatosis and G9a in breast cancer (BCa) cells. This evidence concerns the gene FTH1 and breast carcinoma.